Overview

The Safety and Tolerability of Sub-retinal Transplantation of SCNT-hES-RPE Cells in Patients With Advanced Dry AMD

Status:
Unknown status
Trial end date:
2019-04-01
Target enrollment:
Participant gender:
Summary
To evaluate the safety and tolerability of human somatic cell nuclear transfer embryonic stem cell derived retinal pigmented epithelial(SCNT-hES-RPE) cellular therapy in patients with advanced dry AMD
Phase:
Phase 1
Details
Lead Sponsor:
CHA University